TY - JOUR
T1 - No association between striatal dopamine transporter binding and body mass index
T2 - A multi-center European study in healthy volunteers
AU - van de Giessen, Elsmarieke
AU - Hesse, Swen
AU - Caan, Matthan W A
AU - Zientek, Franziska
AU - Dickson, John C
AU - Tossici-Bolt, Livia
AU - Sera, Terez
AU - Asenbaum, Susanne
AU - Guignard, Renaud
AU - Akdemir, Umit O
AU - Knudsen, Karen Birgitte Moos
AU - Nobili, Flavio
AU - Pagani, Marco
AU - Vander Borght, Thierry
AU - Van Laere, Koen
AU - Varrone, Andrea
AU - Tatsch, Klaus
AU - Booij, Jan
AU - Sabri, Osama
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Introduction: Dopamine is one among several neurotransmitters that regulate food intake and overeating. Thus, it has been linked to the pathophysiology of obesity and high body mass index (BMI). Striatal dopamine D2 receptor availability is lower in obesity and there are indications that striatal dopamine transporter (DAT) availability is also decreased. In this study, we tested whether BMI and striatal DAT availability are associated. Methods: The study included 123 healthy individuals from a large European multi-center database. They had a BMI range of 18.2-41.1kg/m2 and were scanned using [123I]FP-CIT SPECT imaging. Scans were analyzed with both region-of-interest and voxel-based analysis to determine the binding potential for DAT availability in the caudate nucleus and putamen. A direct relation between BMI and DAT availability was assessed and groups with high and low BMI were compared for DAT availability. Results: No association between BMI and striatal DAT availability was found. Conclusion: The lack of an association between BMI and striatal DAT availability suggests that the regulation of striatal synaptic dopamine levels by DAT plays no or a limited role in the pathophysiology of overweight and obesity.
AB - Introduction: Dopamine is one among several neurotransmitters that regulate food intake and overeating. Thus, it has been linked to the pathophysiology of obesity and high body mass index (BMI). Striatal dopamine D2 receptor availability is lower in obesity and there are indications that striatal dopamine transporter (DAT) availability is also decreased. In this study, we tested whether BMI and striatal DAT availability are associated. Methods: The study included 123 healthy individuals from a large European multi-center database. They had a BMI range of 18.2-41.1kg/m2 and were scanned using [123I]FP-CIT SPECT imaging. Scans were analyzed with both region-of-interest and voxel-based analysis to determine the binding potential for DAT availability in the caudate nucleus and putamen. A direct relation between BMI and DAT availability was assessed and groups with high and low BMI were compared for DAT availability. Results: No association between BMI and striatal DAT availability was found. Conclusion: The lack of an association between BMI and striatal DAT availability suggests that the regulation of striatal synaptic dopamine levels by DAT plays no or a limited role in the pathophysiology of overweight and obesity.
U2 - 10.1016/j.neuroimage.2012.09.011
DO - 10.1016/j.neuroimage.2012.09.011
M3 - Journal article
C2 - 22982354
SN - 1053-8119
VL - 64
SP - 61
EP - 67
JO - NeuroImage
JF - NeuroImage
ER -